Ancolio K, Dumanchin C, Barelli H, Warter J M, Brice A, Campion D, Frébourg T, Checler F
Institut de Pharmacologie Moléculaire et Cellulaire du Centre National de la Recherche Scientifique, UPR 411, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne, France.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4119-24. doi: 10.1073/pnas.96.7.4119.
We have identified a novel beta amyloid precursor protein (betaAPP) mutation (V715M-betaAPP770) that cosegregates with early-onset Alzheimer's disease (AD) in a pedigree. Unlike other familial AD-linked betaAPP mutations reported to date, overexpression of V715M-betaAPP in human HEK293 cells and murine neurons reduces total Abeta production and increases the recovery of the physiologically secreted product, APPalpha. V715M-betaAPP significantly reduces Abeta40 secretion without affecting Abeta42 production in HEK293 cells. However, a marked increase in N-terminally truncated Abeta ending at position 42 (x-42Abeta) is observed, whereas its counterpart x-40Abeta is not affected. These results suggest that, in some cases, familial AD may be associated with a reduction in the overall production of Abeta but may be caused by increased production of truncated forms of Abeta ending at the 42 position.
我们在一个家系中鉴定出一种新的β淀粉样前体蛋白(βAPP)突变(V715M-βAPP770),它与早发性阿尔茨海默病(AD)共分离。与迄今报道的其他家族性AD相关的βAPP突变不同,V715M-βAPP在人HEK293细胞和鼠神经元中的过表达减少了总的Aβ生成,并增加了生理分泌产物APPα的回收。V715M-βAPP显著降低了HEK293细胞中Aβ40的分泌,而不影响Aβ42的生成。然而,观察到在第42位终止的N端截短的Aβ(x-42Aβ)显著增加,而其对应物x-40Aβ不受影响。这些结果表明,在某些情况下,家族性AD可能与Aβ的总体生成减少有关,但可能是由在第42位终止的截短形式Aβ生成增加所致。